Michigan Cannabis Sales Show Modest Growth in December
Despite year-over-year increase, medical sales see significant decline
Michigan cannabis sales totaled $269.7 million in December, up 1.6% from the same month last year but reflecting a market that has largely plateaued after years of rapid growth.
Month-over-month, sales rose 3.8%—or just 0.5% when adjusted for the number of selling days.
The Michigan Cannabis Regulatory Agency data shows a stark divide: while adult-use sales continue to dominate, medical cannabis revenue has collapsed. Medical sales fell 50.2% year-over-year, bringing in just $400,000 for the month.
The Medical Market's Decline
Michigan legalized recreational cannabis in 2018, and the medical program has been shrinking ever since. Patients who once needed medical cards to access cannabis can now simply walk into any dispensary.
The numbers tell the story: medical sales that once represented a significant portion of the market now account for less than 0.2% of total revenue.
"We are witnessing an evolution in the market dynamics, where recreational sales are becoming the primary driver," said Robin Schneider, president of the Michigan Cannabis Business Association.
Market Maturation
Michigan's overall sales growth has slowed considerably from the double-digit increases seen in 2021 and 2022. The 1.6% annual gain suggests the market is approaching saturation, at least at current price points.
The state remains one of the largest cannabis markets in the country, but operators are facing increased competition and tighter margins. Wholesale prices have dropped significantly over the past two years.
Looking Ahead
The MCRA will release its next quarterly report in March. Industry observers will be watching for signs of whether the market has stabilized or if further consolidation is coming.
For patients who rely on medical cannabis, the shrinking program raises access concerns. Some dispensaries have reduced their medical inventory as demand drops, potentially limiting options for patients with specific needs.
This article is based on original reporting by New Cannabis Ventures.
Original Source
This article is based on reporting from New Cannabis Ventures.
Read the original articleOriginal title: "Michigan Cannabis Sales Were Soft in December"
Related Topics
Related Stories
Industry NewsIndustry Veteran Calls for Unified Cannabis and Hemp Regulations
Cannabis entrepreneur Jason Leisey argues that maintaining separate regulatory standards for marijuana and hemp products creates dangerous loopholes that threaten consumer trust and industry credibility.
Industry NewsHemp Entrepreneur Fires Back at Industry Critics, Blames Consolidation
Hemp business owner John Grady argues regulatory pressure on hemp products isn't about consumer safety—it's about large cannabis operators using regulation to eliminate competition from smaller hemp companies.
BusinessPre-Rolls Overtake Flower as Top-Selling Cannabis Product in 2024
Pre-rolls became the largest U.S. cannabis product category in 2024, generating $3.6 billion in revenue with 383 million units sold, surpassing traditional flower for the first time.
More from Alex Morgan
View all articles
Massachusetts Halts Cultivation Licenses as Prices Drop to $14/Eighth
Spain's Cannabis Concentrate Market Shifts From BHO to Rosin
Trump Publicly Pressures DOJ on Marijuana Rescheduling Delays
